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Abstract  
  Hypoxia exposure is known to cause biological and pathological alterations and to induce a 
variety of exercise performance benefits that largely depend on skeletal muscle function. Yet, 
adaptive changes in skeletal muscle under hypoxic conditions, as well as their underlying 
mechanisms, are not well described. Because these adaptive changes are assumed to depend 
largely on cellular responses initiated by the stabilization of hypoxia inducible factor (HIF)-α, 
we generated mice lacking prolyl hydroxylase domain (PHD) 2, which is responsible for 
degrading HIF-1α under normoxia. We found that PHD2 deficiency promoted oxidative 
fiber-type switching in skeletal muscle, possibly through the calcineurin/NFATc1 signaling 
pathway, which is a major mediator of muscle fiber determination. PHD2 deficiency also 
resulted in an increased capillary density in skeletal muscles, and this was possibly due to an 
increase in the tissue induction of VEGF. The increased proportion of type I oxidative muscle 
fibers appeared to correspond to the area of higher capillary density. The cross sectional area 
of type I fibers was also significantly increased in both the gastrocnemius and soleus muscles. 
Calcineurin and nuclear NFATc1 protein levels were increased in both the gastrocnemius and 
soleus muscles, suggesting that the calcineurin/NFATc1 pathway was responsible for the type 
I fiber transition regardless of PGC-1α, which responded minimally to PHD2 deletion. 
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Furthermore, we found that FK-506, a calcineurin inhibitor, successfully prevents oxidative 
fiber-type formation in Phd2 cKO. Taken together, our results demonstrated that the hypoxic 
response pathway in skeletal muscle resulted in muscle fibers transitioning toward an 
oxidative phenotype and that this may contribute to improved endurance exercise 
performance.  
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Introduction  
  Hypoxia exposure is known to cause biological and pathological alteration that are 
mediated by the hypoxia inducible factor-α (HIF-α)-dependent signaling pathway(1), and it 
also induces a variety of benefits for exercise performance (2), despite of the obscure 
mechanism on exercise and hypoxia response. The main purpose of hypoxia exposure or 
training is to increase erythrocyte volume and the enhancement of sea level maximal oxygen 
uptake (VO2max) for endurance performance (3); however, other studies reported that the 
respiratory function is deteriorated under hypoxic condition (4). The reduction of respiratory 
function under hypoxia seems to cause various compensatory responses such as increase of 
hemoglobin and activation of angiogenesis (4), and these factors estimates to improve oxygen 
transport to tissues (5). Nevertheless, it is still unclear how these responses influence the 
various tissues such as the heart, the liver, and skeletal muscle both molecularly and 
physiologically. Skeletal muscle in particular is one of the key organs for energy demand and 
production during exercise(6); however, a little information on the impact of hypoxic 
response in skeletal muscle has been reported. Moreover, aerobic metabolism such as TCA 
cycle and electron transport system of skeletal muscle are key processes for endurance 
capacity (7), and it has been known that endurance muscle contraction depends on skeletal 
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muscle fiber type distribution (8,9). Also, it has been still unanswered that improved oxygen 
delivery under hypoxia is able to influence endurance muscle contraction without alteration of 
skeletal muscle fiber structure and function. Additionally, it was reported that hypoxia links to 
muscle fiber transition towards oxidative fiber type through a HIF-1α-dependent manner in 
myoblasts regardless of PGC-1α (10), although the precise mechanism was not elucidated. 
Furthermore, it has been recently reported that a dramatic increase in capillary formation may 
links to muscle fiber type transition (11). Probably, this information provides the possibilities 
that hypoxic response pathway involving in angiogenesis may result in muscle fiber transition 
toward oxidative fiber type. Therefore, improvement of exercise performance by hypoxia 
response pathway may accompany the alteration of biological muscle structures including 
muscle fiber type conversion in conjunction with sufficient oxygen supply for endurance 
capacity.  
  Notably, the distribution of skeletal muscle fiber type is a crucial factor in determining the 
exercise capacity. Mammalian skeletal muscle consists of four isoform of muscle fiber 
including myosin heavy chainⅠ(Slow), and three subtype of typeⅡ	 (Fast): a, b, and x. (12). 
Slow oxidative fiber type is characterized by oxidative metabolism, endurance capacity, 
abundant capillary density, and high resistant to fatigue. In contrast, fast glycolytic fiber types 
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are characterized by glycolytic metabolism, high-speed muscle contraction, and low resistant 
to fatigue (13). Although skeletal muscle fiber type is determined by mainly genetic factor, it 
is mutable by environmental factor such as exercise training (14) or regenerative processes 
after muscle damage (15). However, the alteration of muscle fiber type composition by 
hypoxic response remains unanswered.    
  Under normoxic condition, Prolyl Hydroxylase Domains (PHDs) hydroxylates HIF-α 
subunits, including HIF-1α and HIF-2α, through interactions with E2 ligase von 
Hippel-Lindau protein (pVHL), which results in the ubiquitination and proteasomal 
degradation of HIF-α isoforms (Kyle A. Rasbch et al, 2010). Under hypoxic condition, 
however, hypoxia inducible factor (HIF), which contains of an O2-sensitive α-subunit, is 
stabilized by inactivated Prolyl hydroxylase domain (PHDs) (16). The three isoforms, PHD1, 
2 and 3, are each essential factors in a variety tissues, particularly in response to hypoxia 
condition. PHDs inactivation allows for the stabilization and accumulation of HIF-α isoforms 
in nucleus, where they induce the expression of various hypoxia-responsive genes. PHD2 not 
but PHD1, and 3, known as a main isoform for the control Hypoxia-Inducible Factor (HIF) 
level under normoxia (16,17). In addition, PHD2 is mainly involved in the hypoxic response 
(16), and is a key factor for angiogenesis and erythropoiesis through the stabilization of 
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HIF-1α and HIF-2α respectively (18). Moreover, VEGF expression stimulated by HIF-1α is a 
crucial mediator for angiogenesis, and it has been reported that VEGF is associated with 
Calcineurin/the nuclear factor of activated T cells (NAFT) signaling in angiogenesis (19,20). 
The nuclear translocation of NFAT is strongly linked to muscle fiber type transition program 
in skeletal muscle. Indeed, it was demonstrated that calcineurin/NFAT pathway is activated 
by hypoxia stimuli through the increase of intracellular calcium levels (21). 
Calcineurin/NFAT signaling is known as one of the major mediator for muscle fiber type 
switching (22,23). Calcineurin dephosphorylates NFAT family proteins (NFATc1, c2, c3, and 
c4) in the cytoplasm (13), thereby allowing NFAT to translocate into the nucleus, where it 
interacts with other transcription factor such as MEF2 and p300 to activate various target 
genes, including slow fiber type gene (24). Notably, among NFAT isoform, NFATc1 plays an 
essential role in regulating muscle fiber transition to slow fiber type (25). Thus, hypoxic 
response pathway may results in skeletal muscle fiber type shift toward oxidative fiber type 
via calcineurin/NFATc1 signaling pathway. We hypothesize that the expression of VEGF by 
HIF-1 stabilization in Phd2 deficiency mice plays a crucial role in muscle fiber type transition 
toward oxidative fiber type through calcinuerin/NFATc1 signaling pathway.  
  In order to observe the role of hypoxia response in skeletal muscle, we employed Cre-loxP 
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system to generate a mouse in which PHD2 is deleted upon activation of calcium-dependent 
recombinase (Cre), because Phd2 knockout is embryonic lethal (18). In this research, we 
indicate that calcineurin/NFATc1 pathway regulates the myosin heavy chain (MHC) isoform 
using Phd2 deficiency mice. Collectively, this research demonstrates that VEGF expression 
by HIF-1α in Phd2 deficiency mice induces increase of oxidative fiber type by 
calcineurin/NFATc1-dependent pathway.  
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Methods  
Generation of cKO mouse  
  All animal experimental procedures were performed according to the protocols approved 
by the Guidelines for the Care of Laboratory Animals of Tohoku University Graduate School 
of Medicine (Sendai, Japan). The PHD2f/+ mice were generated previously (f denotes floxed 
allele). To delete floxed PHD2 exon 2, tamoxifen (Sigma, St Louis, Mo) was administered to 
10-week-old PHD2f/fRosa26/CreERT2 mice by forced gavages (20 mg/mL in corn oil, 0.5 
mg/d for 7 consecutive days). The Rosa26/CreERT2 mice used to establish the 
PHD2f/fRosa26/CreERT2 colony were provided by Connecticut University.  
  To characterize skeletal muscle phenotype, soleus and gastrocnemius were harvested from 
Phd2f/f and Phd2 cKO mice after the mice were sacrificed by cervical dislocation, and then 
the muscle samples were stored at -80°C. FK506 (Enzo Life Sciences) was dissolved in 
ethanol, and PBS, and it was administered subcutaneously; the dose of FK506 was 1 mg per 
kg body weight per day for 7 consecutive days. To monitor the deletion of PHD2 exon 2, as 
well as the presence of the Rosa 26CreERT2 allele, tail DNA samples were prepared and used 
for polymerase chain reaction (PCR) before and after tamoxifen administration. 
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Blood analysis  
  Blood samples (0.5-1.0 ml) were obtained from mouse facial veins. Blood profiles (Red 
blood cells, hematocrit, and hemoglobin) were measured using a multi-automatic blood cell 
counter for animals (MICRO abc LC-152, Horiba, Tokyo, Japan).   
 
Protein preparation and Western blotting  
  To isolate total protein extracts, 50 mg of skeletal muscle tissue was homogenized for 30 s 
on ice in 1 ml of lysis buffer (40 mM Tris (pH 7.5), 300 mM KCl, 1% Triton X-100, 0.5 M 
EDTA, Protease inhibitor cocktail X 20 (Sigma)), using a Polytron PT-MR 2100 
homogenizer. Homogenates were centrifuged at 12,000 rpm for 5 min at 4°C, and the 
supernatants were isolated. Protein concentrations were determined using the BCA protein 
assay kit (Thermo Fisher Scientific, Rockford, IL) with BSA as the standard, and extracts 
were stored at -80°C. Nuclear and cytoplasmic extractions were performed using the NE-PER 
nuclear and cytoplasm extraction reagents (78833, Thermo Fisher Scientific).  
  Total protein was separated via 8-12% SDS-PAGE and transferred to a PDVF membrane 
(Invitrogen). The membrane was blocked using Tris-buffered saline with 0.05% Tween 20 
(TBST) containing 5% BSA for 1 h and incubated overnight with appropriately diluted 
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(1:500-1000) primary antibody in TBST at 4°C. After incubation, membranes were rinsed 
three times in TBST for 5 min and incubated with secondary antibody in 4% skim milk for 1 
h at room temperature. Protein bands were visualized and quantified using a Molecular 
Imager VersaDoc 5000MP system (Bio-Rad) and ECL.  
  The following primary antibodies were used: Monoclonal Anti-Myosin slow (M8421, 
Sigma), MYH2 antibody (A4.74, Santa Cruz Biotechnology), Anti-PGC-1α (AB3243, 
Millipore), Anti-Calcineurin pan A (07-1491, Millipore), HIF-1α (NB100-105, Novus), 
NFATc1 (sc-7294, Santa Cruz Biotechnology), myoglobin (FL-154, Santa Cruz 
Biotechnology), β-actin (AC-74, Sigma-Aldrich), GAPDH (14C10, Cell signaling 
Technology).   
 
Histology  
  Determination of Muscle fiber type composition - Gastrocnemius, Soleus, and Tibialis 
Anterior muscle samples were harvested from PHD2f/f and PHD2 cKO mice, snap frozen, 
and embedded in O.C.T. compound (4583, Sakura) in methylbutane for cryosectioning. 
Skeletal muscle cryosections were air dried for 10 min and fixed with 4% Paraformaldehyde 
(PFA) for 15 min. For muscle fiber-type composition experiments, sections were blocked in 
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PBS containing 0.3% Triton X-100 and M.O.M mouse blocking reagent (Vector 
Laboratories) for 1 h at room temperature. Primary antibodies were incubated overnight at 
4°C. We used several primary antibodies, such as Monoclonal Anti-Myosin slow (M8421, 
Sigma), Myosin heavy chain 2A (SC-71, Developmental Studies Hybridoma Bank, Iowa), 
and anti-laminin antibody (L9393, Sigma-Aldrich) in the blocking solution with M.O.M 
protein concentrate (Vector Laboratories). Section samples were incubated with secondary 
antibodies in PBS for 1 h at room temperature. We used several secondary antibodies, such as 
Alexa Fluor 488 Goat Anti-mouse IgG and Alexa Fluor 555 Goat Anti-rabbit IgG in PBS 
containing 0.3% Triton X-100. All slides were covered with Vectashield mounting medium 
with DAPI (Vector Laboratories). Samples were visualized on a microscope (C2+, Nikon) 
and analyzed using NIS elements and ImageJ software. 
  Determination of capillary density - Frozen sections were blocked in PBS containing 
0.3% Triton X-100 and 10% goat serum (Sigma) for 1 h at room temperature. Anti-mouse 
CD31 (PECAM-1, BD Pharmingen) was used as the primary antibody and was incubated 
overnight in blocking solution at 4°C. Alexa Fluor 488 Goat Anti-Rat IgG in blocking 
solution was used as the secondary antibody for 1 h at room temperature. All slides were 
covered with Vectashield mounting medium (Vector Laboratories). Detection was performed 
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on a microscope (C2+, Nikon), and images were analyzed using NIS elements software. The 
fields of whole muscle tissue cross-section from soleus and gastrocnemius were entirely 
selected for CD31-positive cells counting, and analyzed using ImageJ software. 
 
RNA extraction and Real Time Quantitative PCR  
 RNA extraction and Real-Time Quantitative PCR. Total RNA from muscle tissues was 
isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. cDNA 
templates were obtained via reverse transcription of 2 µg of total RNA (QuantiTect Reverse 
Transcription; Qiagen). Quantitative RT-PCR was performed in a 96-well plate format using 
the Fast SYBR Green PCR master mix and the StepOnePlus Real-Time PCR system (Applied 
Biosystems). The thermal cycling conditions were as follows: 95°C for 7 min, followed by 40 
cycles of 95°C for 10 sec and 60°C for 30 sec, and a final extension of 95°C for 15 sec and 
60°C for 30 sec. Relative expression was calculated using the standard method. All values for 
each gene were averaged and normalized to β-actin or 18S as an internal control. The 
following primer sequences were used:  
Phd2 forward, 5’-GCCCAGTTTGCTGACATTGAAC-3’;  
Phd2 reverse, 5’-CCCTCACACCTTTCTCACCTGTTAG-3’ 
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VEGF-A forward, 5’CCACGTCAGAGAGCAACATCA-3’;  
VEGF-A reverse 5’-TCATTCTCTCTATGTGCTGGCTTT-3’ 
β-actin forward, 5’CTGGGTATGGAATCCTGTGG-3’; 
β-actin reverse 5’GTACTTGCGCTCAGGAGGAG-3’ 
 
Immunoassay  
  VEGF concentrations were determined from gastrocnemius samples from Phd2f/f and 
Phd2 cKO mice using a mouse VEGF Immunoassay kit (R&D system, Japan). Briefly, 
muscle samples were prepared from gastrocnemius homogenates in 1.5 ml of 1X PBS. The 
homogenates were subjected to two freeze-thaw cycles to break the cell membranes and 
centrifuged for 5 min at 5000 x g. The VEGF immunoassay was carried out according to the 
manufacturer’s protocol.  
 
Muscle damage model  
  10 to 12 weeks old of Phd2f/f and Phd2 cKO mice were anesthetized and subsequently 
injected with cardiotoxin (CTX; Naja mosaambica mossambica, Sigma Aldrich). We injected 
100µl of 10µM of cardiotoxin in right gastrocnemius for muscle damage, and 100µl of saline 
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solution was injected into left gastrocnemius for control using a 27-gauge needle. Muscles 
were harvested at 7, 14, 21, and 28 day after cardiotoxin injection.  
 
Treadmill Exercise Training and Test  
  Exercise group was divided into four groups (Phd2f/f and Phd2 cKO of training and 
Phd2f/f and Phd2 cKO of non-training). Pre-exercise test was performed at 2 weeks after 
tamoxifen administration, and post-exercise test was carried out at 4 weeks after pre-exercise 
test using treadmill. Endurance capacity exercise test protocol sets up as a warm up of 10 min 
at 10m/min, and running speed was increased 2m/min every 15min until exhaustion. Exercise 
training was performed a warm-up 10 min 5, and running speed was increased 2m/min every 
5min. Exercise training was carried out 5 times every week for 4 weeks.   
    
Statistical Analysis  
  All results are expressed as the means with error bars representing standard errors. 
Two-tailed Student’s t-tests were performed to determine p values. Statistical significance 
was defined as p<0.05.  
 
 17 
Results  
 
Phd2 expression is efficiently reduced by Tamoxifen administration  
	 To inhibit the activation of Phd2 at the adult stage, we generated Phd2f/f/Rosa26+/CreERT2 
mice. The administration of Tamoxifen at 8-12 week of age activated Cre recombinase, and 
resulted in the generation of conditional knockout (cKO) mice. We confirmed that the 
deletion of the floxed exon 2 by examining protein level from Phd2f/f/Rosa26+/CreERT2 and 
Phd2f/f mice after tamoxifen administration (Figure 2A). In addition, we evaluated the 
efficiency of PHD2 deletion in the gastrocnemius muscles of tamoxifen-treated 
Phd2f/f/Rosa26+/CreERT2 mice using RT-qPCR. The level of mRNA was decreased by 46% in 
the Phd2 cKO mice compared with the Phdf/f mice (Figure 2B).   
 
Phd2 deletion induces alteration of blood profiles and muscle phenotype.   
	 To monitor the alteration of blood profiles in response to Phd2 inactivation, we obtained 
blood samples from the facial vein of both the Phd2f/f and Phd2f/fRosa26+/CreERT2. Deleting 
Phd2 caused the alteration of blood components: hemoglobin (Phd2f/f: 15.43, Phd2 cKO: 
22.98g/dl), red blood cell (RBC), (Phd2f/f: 10.16, Phd2 cKO: 17.93 103/mm3) and hematocrit 
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(Phd2f/f: 49.6, Phd2 cKO: 74.7%) were all significantly increased at 4 week after tamoxifen 
treatment (Figure 2A-C)(p<0.01)(P15). (Figure 3A-C). In addition, skeletal muscle phenotype 
was changed by Phd2 deficiency. Normally, the soleus is a slow fiber-enriched muscle, 
whereas gastrocnemius is a fast fiber-enriched muscle. However, both the soleus and 
gastrocnemius muscle of Phd2 cKO mice showed a more red coloration than those of the 
Phd2f/f mice (Figure 3D). Furthermore, the body weight and skeletal muscle weight (both of 
soleus and gastrocnemius) were significantly decreased in the Phd2 cKO mice compared with 
Phd2f/f mice (Table 1). 
 
Phd2 deletion induces the angiogenesis  
	 To verify the hypoxic adaptation response upon Phd2 deletion, we examined the activation 
of angiogenesis by HIF-1α expression in skeletal muscle and confirmed the expression of 
HIF-1α in gastrocnemius in Phd2 cKO mice (Figure 2C). Additionally, we determined VEGF 
concentration (Phd2f/f: 36.6, Phd2 cKO: 45.1 pg/mL) and VEGF mRNA levels (2.36 fold 
increased in Phd2 cKO) in skeletal muscle tissue (Figure 4A), and monitored the capillary 
density in skeletal muscle by immnostaining for CD31, which is an endothelial cell marker in 
both the soleus and gastrocnemius. Based on these experiments, we were able to confirm the 
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expression of VEGF in gastrocnemius, and we found that CD31-positive cells were 
significantly increased in both the soleus and gastrocnemius muscles of the Phd2 cKO mice 
(Figure 4B). 
The inactivation of Phd2 results in skeletal muscle fiber type transition toward oxidative 
fibers  
	 The inactivation of PHD2 in the whole body, including in skeletal muscle, results in muscle 
fiber-type conversion toward the oxidative fiber type. We demonstrated an increase in slow 
muscle fibers in soleus and gastrocnemius muscles. We performed immunostaining to 
observe the number of muscle fibers and found that the proportion of slow muscle fibers in 
the Phd2 cKO mice was significantly increased in the soleus muscle (35.8% in Phd2f/f vs 
46.7% in Phd2 cKO, p<0.01) (Figure 5B). The number of slow muscle fibers in the 
gastrocnemius in the Phd2 cKO mice was also higher than in the Phd2f/f mice (0.94% vs 
1.89%, p<0.01) (Figure 5B). In addition, the number of type IIa muscle fibers in the 
gastrocnemius was increased in the Phd2 cKO mice, whereas the type IIa muscle fiber type 
was not significantly altered in the soleus muscle (Phd2f/f 48.48% vs Phd2 cKO 46.88%) 
(Figure 4C). Type IIx +b (unstained) fibers were significantly decreased in the soleus muscles 
of the Phd2 cKO mice (16.9% in Phd2f/f vs 6.24% in Phd2 cKO) (Figure 6B). The muscle 
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fiber-type conversion observed in the Phd2 cKO mice indicated time-dependent changes in 
the proportion of slow fiber type. Slow muscle fibers were increased from 5 weeks and 6 
weeks after tamoxifen treatment. However, the proportion of muscle fiber types was unaltered 
between the Phd2 cKO and Phd2f/f mice at 4 weeks after tamoxifen (Figure 6A). Additionally, 
Western blotting indicated an increase in MyHC I protein levels in both the soleus and 
gastrocnemius (Figure 5D), whereas MyHC IIa protein levels were not changed in both the 
soleus and gastrocnemius muscle (Figure 5E). These data are in agreement with the 
histological results. 
 
Muscle damage induces increase of slow fiber type in gastrocnemius during muscle 
regeneration  
  To evaluate whether muscle damage links to muscle fiber type conversion during muscle 
regeneration, we induced cardiotoxin-induced muscle damage model. And we determined the 
protein content and distribution of muscle fiber type using immunostaining.	 
Cardiotoxin-induced muscle injury results in increase of slow fiber distribution in 
gastrocnemius (Figure 7A). Gastrocnemius after damage showed time-dependent change in 
the number of slow fiber type. The number of slow muscle fibers was increased at 3 week 
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after cardiotoxin-induced damage (Figure 7B). Whereas, slow muscle fibers of damaged 
muscle in Phd2 cKO mice were significantly increased from 2 week after CTX injection. In 
addition, the rate of increase in slow muscle fibers in Phd2 ckO mice was higher than Phd2f/f 
mice. These data indicate that muscle fiber regeneration after damage induces transformation 
of slow muscle fiber, and Phd2 deletion enhanced muscle fiber type transition toward to 
oxidative fiber.   
  
Calcineurin/NFATc1-dependent pathway may involve in muscle fiber transition 
program, but not PGC-1α pathway.   
  We demonstrated that deleting Phd2 promotes angiogenesis via HIF-1α stabilization, and 
enhances the oxidative muscle fiber phenotype in both the soleus and gastrocnemius muscles. 
We examained several factors associated with muscle fiber transition, such as PGC-1α, 
myoglobin, calcineurin, and NFATc1, to investigate the mechanism underlying the induction 
of slow muscle fiber formation. Our results indicated that the expression of PGC-1α was 
slightly decreased by Phd2 cKO, and that myoglobin expression was unchanged in both the 
soleus and gastrocnemius (Figure 8A). By contrast, the expression of calcineurin was 
significantly increased in both the soleus and gastrocnemius of Phd2 cKO mice (Figure 8B). 
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Furthermore, we verified the nulclear translocation of NFATc1 in both the soleus and 
gastrocnemius in Phd2 cKO mice (Figure 8C). Also, we confirmed that no change of PGC-1α, 
but calcineurin was increased in skeletal muscle damage-induced by cardiotoxin.  
 
Tacrolimus suppresses slow fiber-type transformation in soleus of Phd2 cKO mice  
	 To verify the role of calcineurin/NFATc1 signaling in slow muscle fiber-type transition, we 
administrated FK506, which is calcineruin inhibitor, at 4 week after tamoxifen treatment for 7 
consecutive days. The administration of FK506 results in preventing slow muscle fiber-type 
transition in soleus of Phd2 cKO mice (Figure 9A, B). 
 
The exercise training improved the endurance capacity in Phd2 deficiency mice  
  We performed treadmill running test and exercise training 5 times every week for 4 weeks 
using Phd2 deficiency mice. Endurance running capacity had no different between Phd2f/f and 
Phd2 cKO (figure 10A), whereas endurance exercise capacity after treadmill training was 
increased in both of trained-Phd2f/f and Phd2 cKO mice compared with non-training group. 
In addition, the effect of exercise training in Phd2 cKO was significantly higher than Phd2f/f 
mice (figure 10B).   
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Discussion    
 
  In the current study, we investigated the role of hypoxic response pathway in skeletal 
muscle using Phd2 deficiency mice. Our results indicated that HIF-1α-dependent hypoxic 
response pathway by Phd2 deletion involved in skeletal muscle fiber-type transition toward 
oxidative phenotype possibly occurred through interaction with capillary density and the 
calcineurin-NFATc1 dependent pathway. Thus, we found that the hypoxia adaptation 
response pathway results in the alteration of skeletal muscle phenotype regardless of oxygen 
level, which underscore the effect of hypoxia adaptation responses on endurance exercise 
capacity.  
  Mammalian adapts to chronic hypoxic condition through the pathway increasing the 
appropriate oxygen delivery, and reducing oxygen consumption via angiogenesis, 
erythropoiesis, and activation of glycolysis (26). In this regard, Exposure to hypoxia results in 
the activating glycolytic pathway enzymes of phosphofructokinase (PFK), glucose transport, 
and pH-regulation. In contrast, muscle oxidative capacity under hypoxia is still controversial. 
Although some researches found increased mitochondrial density or citrate synthase activity, 
some studies reported oxidative and fat oxidation are suppressed in human muscle under 
hypoxia (27). Also, skeletal muscle adaptations are specific to the type of exercise stimuli, 
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and that the combination of exercise and hypoxia may have synergistic effect on skeletal 
muscle adaptations in HIF-dependent pathway (28). However, the mechanism of HIF-α in 
skeletal muscle still remains unclear. Thus, our study demonstrated that the alteration of 
skeletal muscle phenotype via calcineurin/NFATc1 signaling pathway by HIF- α 
stabilization.  
  Also, hypoxia adaptation pathway is activated by the inhibition of oxygen-dependent PHDs 
activities, which are associated with accumulation of HIF-α subunits and activation of target 
genes related to angiogenesis and erythropoietin. PHD2 is an oxygen-level-dependent PHD 
isoform that regulates the stabilization of HIF-α under hypoxic conditions (16,29). We found 
that the deletion of PHD2 results in the stabilization of HIF-α in skeletal muscles under 
normoxia. The inhibition of hydroxylase activity leads to HIF-α translocation into the nucleus, 
where it regulates a variety of target genes related to angiogenesis, erythropoiesis and energy 
metabolism (30). The induction of HIF-1α overexpression by PHD2 deficiency has been 
shown to activate the angiogenic response and erythropoiesis(18,31,32). 
  Indeed, we found that Phd2 deficiency results in several alterations such as the increase of 
red blood cell, hemoglobin, hematocrit, the reduction of body weight and skeletal muscle 
weight and activation of angiogenesis. Although the precise mechanism has not been 
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elucidated, these hypoxic responses seem to trigger oxidative fiber-type formation. Prior work 
has shown that erythropoietin not only contributes to oxidative muscle fiber-type gene 
expression but that it also increases mitochondrial activity via PGC-1α, a master regulator of 
mitochondria biogenesis and skeletal muscle fiber-type determination, and AMPK activation 
(33,34); however, PGC-1α expression was negatively regulated by Phd2 deficiency in both 
the soleus and gastrocnemius muscle despite the activation of erythropoiesis. These data are 
consistent with a previous report that PGC-1α was suppressed under hypoxic conditions (10).  
 
Skeletal muscle fiber-type transition toward oxidative phenotype in PHD2 deficiency 
mice  
  Our results nevertheless revealed that the hypoxic response pathway is involved in the 
skeletal muscle fiber-type transition toward the oxidative phenotype. Likewise, skeletal 
myoblast under hypoxia (4%O2) showed an increase of oxidative myosin heavy chain 
(MyHC) isoforms and decrease of glycolytic MyHC isoforms regardless of PGC-1α in vitro 
(10). Moreover, they demonstrated that hypoxia induced not only decrease in protein content 
of the oxidative phosphorylation (OXPHOS), but also increase in the gene expression of 
glycolytic enzyme hexokinase-II (10). Paradoxically, even though this report showed the 
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activation of glycolytic energy metabolism, the muscle cell was altered toward oxidative 
phenotype. These paradoxical phenomena are still obscure. Although the precise signaling 
pathway through which the hypoxic response induced by PHD2 deficiency is linked to 
oxidative muscle fiber-type transformation independent of PGC-1α has not been elucidated, 
the HIF-α, an essential mediator of oxygen homeostasis (35), may the key regulator of 
oxidative muscle fiber-type transition program.   
  Interestingly, we found an increase in the capillary density in both the soleus and 
gastrocnemius muscles in the PHD2-deficient mice. Specifically, augmented CD31-positive 
cells, a marker of endothelial cells, were preferentially localized in the oxidative fiber type 
compared with the glycolytic fiber type. Functionally, increased capillary density seems to be 
necessary for muscle fiber-type switching (11). In addition, vascular endothelial growth factor 
(VEGF) plays a crucial role in physiological and pathological angiogenic processes (36), and 
we confirmed the increase of VEGF-A level in skeletal muscle. Notably, VEGF induces 
increased intracellular Ca2+, which leads to the activation of calcineurin and the nuclear 
translocation of NFATc1 in endothelial cells (19,20,37). Probably, VEGF may be associated 
with the oxidative fiber-type transition through capillary density formation via 
calcium-dependent calcineurin/NFAT signaling.  
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Slow muscle fiber transformation via calcineurin/NFATc1 signaling 
  Furthermore, we found an activation of calcineurin/NFATc1 signaling in both Phd2 cKO 
and muscle damage mice. Calcineurin is well known as a Ser/THr phosphatase, the activity of 
pivotal regulator of oxidative muscle phenotypes and metabolism; skeletal muscle 
specific-transgenic mice expressing activated calcineurin enhanced endurance exercise 
capacity (38). Calcineurin participates in various cellular signaling and activation processes 
such as proliferation, survival, development, and cell differentiation in various cell types 
(19,39), as well as the muscle fiber-type transition program (22,40) and muscle mass (41). 
The activation of calcineurin results in the dephosphorylation of NFATs, which are the main 
downstream targets of calcineurin, leading to their nuclear translocation and triggering of 
transcription factors related to slow fiber-type formation (23). Each NFAT isoform (c1, c2, c3, 
and c4) not only plays a role in the development and growth of skeletal muscle but also 
regulates the oxidative muscle fiber-type program (23,42). In particular, NFATc1 interacts 
with MyoD, MEF2, and the transcriptional coactivator p300 (22-24) and enhances the 
promoter activity of MyHC I in rodent skeletal muscle (43). Indeed, Phd2 deficiency mice 
showed the activation of calcineurin and NFATc1 nuclear translocation in skeletal muscle. 
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Moreover, muscle injury-induced CTX induces calcineurin/NFATc1 expression in both of 
Phd2 cKO and Phd2f/f mice. However, the slow muscle fiber-type formation was early started 
by muscle injury in Phd2 cKO compared with Phd2f/f mice. Additionally, the increase rate of 
slow muscle fibers in Phd2 cKO was higher than Phd2f/f mice after muscle damage. These 
results indicate that calcineurin is increased in hypoxic response as well as muscle 
regeneration process.  
 Next, we administrated FK-506, which is known to prevent dephosphorylation of NFATc1 
via inhibition of calcineurin, whether calcineurin and the NFATc1 nuclear translocation leads 
to skeletal muscle fiber-type transition in hypoxic-responsive pathway. The administration of 
calcineurin inhibitor FK506 or cyclosporine causes to prevent overload-induced fiber type	 
IIb →	 II(x)	 → IIa → I fiber shift through the dephosphrylation of NFATc1 in skeletal 
muscle of mice (44). In our study, the inactivation of calcineurin by FK506 successfully 
prevented slow muscle fiber-type transformation in Phd2 deficiency mice. This data indicated 
that the suppression of calcineurin increase prevent slow muscle fiber-type formation in 
hypoxic response pathway. Therefore, the calcineurin might be a key regulator for muscle 
fiber-type transition program toward oxidative fiber via angiogenesis in hypoxic-responsive 
pathway.  
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  However, the interplay between angiogenesis and calcineurin/NFAT signaling in the 
hypoxic response remains unanswered. Besides, one limitation of our study is that we are 
unable to exclude the possibility that is altered by oxygen concentration in skeletal muscle, 
because our model only targeted the stabilization of HIF-α by PHD2 deletion to induce 
hypoxic-responsive pathway regardless of oxygen concentration. Another limitation is that we 
did not rule out the impact of systemic alteration such as erythropoiesis from kidney, and the 
systemic angiogenic response on skeletal muscle fiber-type shift. In this regard, further 
studies are required to clarify the association with between angiogenesis including VEGF 
expression and calcineurin in the hypoxic response pathway, and to verify whether skeletal 
muscle fiber-type transition is attributed to the stabilization of HIF-α by PHD2 deletion in 
skeletal muscle or not using muscle-specific Phd2 knock out mice.   
 
PHD2 deletion improves the effect of exercise training 
  Moreover, our data showed the effect of exercise training in Phd2 deficiency. Even though 
hypoxic response by Phd2 deletion leads to the increase of endurance exercise capacity, it 
remains unclear which the alteration such as blood profiles and skeletal muscle phenotype in 
hypoxic-responsive pathway is attributed to improved exercise capacity. However, the 
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activation of angiogenesis and muscle fiber type transition by hypoxic response may links to 
the increase of exercise training efficiency.   
 
 Conclusion 
 In summary, the current study found that the stabilization of HIF-α by PHD2 deletion results 
in the increase of capillary density, and activates the oxidative muscle fiber-type transition 
program via calcineurin/NFATc1-dependent signaling pathway regardless of oxygen 
concentration. Our novel findings indicate that calcineurin/NFATc1 signaling is a key 
mediator responsible for oxidative myosin heavy chain transformation in the hypoxic 
adaptation response. These findings suggest that prolonged hypoxic exposure may regulate 
skeletal muscle oxidative fiber-type determination, possibly via calcineurin/NFATc1 
signaling pathway. 
  Collectively, our novel findings may provide a basis for the alteration of skeletal muscle 
phenotype in HIF-α-dependent hypoxic-responsive pathway. The alteration of the skeletal 
muscle fiber-type distribution toward oxidative phenotype under hypoxic response may be 
one of the reasons for improved exercise performance.   
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Figure legends  
Table 1. The body weight and skeletal muscle mass. Skeletal muscle and body weight were 
significantly decreased by Phd2 deletion  (n = 15 per group). *p<0.05, **p<0.01 compared 
to control. Values are means ± SEM. 
 
Figure 1. The schematic figure for hypothesis   
 
Figure 2. Tamoxifen administration-induced PHD2 deletion in skeletal muscle in 
Phd2f/f/Rosa26/CreERT2 mice. (A) Anti-PHD2 Western blotting of gastrocnemius at 6 week 
after tamoxifen administration. (B) PHD2 deletion efficiency in the gastrocnemius muscles of 
tamoxifen-treated Phd2f/f/Rosa26/CreERT2 mice was determined via qRT-PCR. Relative gene 
expression was determined using gastrocnemius muscle tissue cDNA. (n = 3-4 mice per 
group). (**p<0.01). (C) The expression of HIF-1α in gastrocnemius at 5 week after tamoxifen 
administration. Data shown are means ± SE (**<0.01).    
 
Figure 3. The alteration of blood profiles and the altered phenotype of skeletal muscle    
This data shows the alteration of blood profiles at 6 week after tamoxifen administration. (A) 
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Red blood cell count (B) Hemoglobin level (C) Hematocrit value (n = 10 per group). (D) 
Appearance of skeletal muscles, including soleus and gastrocnemius, in Phd2f/f and Phd2 
cKO mice. Data shown are means ± SE (*p<0.05, **p<0.01, n = 15)    
 
Figure 4. Phd2 deletion induces angiogenesis in skeletal muscle.  
(A) The VEGF level in skeletal muscle was measured by Elisa. (n = 3 per group) (B) Relative 
gene expression was measured using gastrocnemius muscle tissue cDNA. (n = 3 per group) 
(C) The capillary density in skeletal muscles was determined by detecting CD31-positive 
cells using immunostaining. (n = 5 per group). *p<0.05, compared to control. Data shown are 
means ± SE.  
 
Figure 5. Phd2 deficiency elicits oxidative muscle fiber type in both the soleus and 
gastrocnemius. (A) Muscle fiber type was analyzed by immunostaining. The frozen sections 
of the soleus and gastrocnemius muscle at 6 week after tamoxifen treatment were stained with 
antibodies for MHCⅠ/slow (green), MHCⅡa /fast (green) and counterstained for laminin 
(red). (B) The proportion of slow muscle fibers was measured using ImageJ software 
(**p<0.01, n=5).  (C) Western blotting confirmed protein level in soleus of Phd2f/f and Phd2 
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cKO mice (n=3). Data shown are means ± SE. (scale bar = 100µm) 
 
Figure 6. The time-dependent increase of slow muscle fiber type and the total proportion 
of muscle fiber types. (A) The increase in the slow muscle fiber type was analyzed in a 
time-dependent manner (**p<0.01, n = 5). (B) The total proportion of muscle fiber types in 
the soleus at 6 weeks after tamoxifen administration (*p<0.05, **p<0.01, n = 5). 
 
Figure 7. Muscle injury-induced cardiotoxin results in slow muscle fiber transformation 
in both of Phdf/f and Phd2 cKO mice. (A) Histological analysis of muscle fiber type, frozen 
section of gastrocnemius was stained with slow fiber typ. (B) The increase of slow fibers after 
muscle damage-induced by cardiotoxin in Phd2 deficiency mice. Data shows means ± SE 
(*p<0.05 **p<0.01, n = 3). 
 
Figure 8.	 Phd2 deletion induced the expression of calcineurin but not PGC-1α and 
myoglobin, as well as nuclear translocation of NFATc1. (A) Western blotting analysis of 
protein lysates from the gastrocnemius and soleus for PGC-1α and myoglobin. Calcineurin 
protein levels were measured using Western blotting in the gastrocnemius at 5 weeks after 
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tamoxifen administration (**p<0.01, n=3). (C) Western blotting analysis of nuclear protein 
extracts in the soleus and gastrocnemius at 6 weeks after tamoxifen administration (*p<0.05, 
n=3). Data shown are means ± SE.   
 
Figure 9. The effect of FK-506 treatment on the myosin heavy chain (MyHC) 
composition in soleus muscle of Phd2 deficiency mice  
(A) The treatment of FK-506 for 7 days at 4 week after tamoxifen administration prevent to 
increase in the proportion of slow muscle fiber-type (n = 4 per group). **p<0.01 compared to 
control. Data shown are means ± SE (scale bar = 100µm). 
 
Figure 10. Exercise training improves endurance capacity in Phd2 cKO mice. (A) The 
result of treadmill running test in non-trained Phd2f/f and Phd2 cKO mice (n=5). (B) The 
result of treadmill running test before and after endurance training in Phd2f/f and Phd2 cKO 
mice (*p<0.05 **p<0.001, n=6).    
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Table 1.	
Phd2f/f Phd2 cKO  p value  
n=11 n=13 
Soleus (mg) 8.57 ± 0.91 5.79  ± 1.3 p<0.01 
Gastrocnemius (mg) 161.85 ± 14.82 116.15 ± 18.46 p<0.01 
Soleus/BW (mg/g) 0.31 ± 0.03 0.26 ± 0.04 p<0.01 
Gastrocnemius/BW (mg/g) 5.92 ± 0.22 5.26 ± 0.25 p<0.01 
Body Weight (g) 27.3 ± 2.42 22.0 ± 2.72 p<0.01 
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